1. Home
  2. Clinical Topics
  3. FDA approves Onfi for seizures associated with Lennox-Gastaut syndrome
Clinical TopicsDrugs and DevicesNeurologyNewsPediatricsWeb Exclusives

FDA approves Onfi for seizures associated with Lennox-Gastaut syndrome

Share

The U.S. Food and Drug Administration has approved Onfi (clobazam) for use as an adjunctive treatment for seizures associated with Lennox-Gastaut syndrome in adults and children 2 years of age and older. Read more.

Leave a Reply

Your email address will not be published. Required fields are marked *

Fill out this field
Fill out this field
Please enter a valid email address.

cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • Hidden

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.

Poll

What has the flu season been like so far?

Recent Posts